Of the seven principles set out in the Council for International Organizations of Medical Sciences Working Group (CIOMS) ...
In this week's Pharma Pulse, new Medicaid pricing deals are rumored, employer GLP-1 pullback, and McKesson's $2.25B oncology ...
Cardinal Health's Michelle Britt discusses the policy changes needed to secure independent pharmacy's future, from state advocacy wins to giving pharmacists a seat at the table. Independent pharmacies ...
TrumpRx passed its six-month mark with more than 800 listed products and a new commitment from 10 pharmacy benefit managers to surface its cash prices at the point of prescribing.
Similar activation models can strengthen trial recruitment, precision medicine, and population health by converting data into ...
Virtual care's pre- and post-visit windows offer pharma marketers a more targeted, attentive audience than physical waiting rooms, new research shows, and most brands aren't capitalizing on it yet.
Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...
Cardinal Health's Michelle Britt discusses how independent pharmacies are expanding clinical services and leaning on ...
Health care's real challenge isn't more data, it's activation. Arcadia's Sandy Leonard on turning real-world evidence into point-of-care action.
EVERSANA's Vikram Anand explains how disconnected PV systems and manual safety processes can create commercial delays after ...
As specialty therapies become more complex, research continues to show that educational, emotional, and practical barriers can influence whether patients initiate therapy and remain engaged over time.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results